On November 14, The Carlyle Group announced that it was purchasing Tarrytown Expocare Pharmacy from Sheridan Capital Partners for an undisclosed amount.
Tarrytown Expocare Pharmacy is a long-term care specialty pharmacy focused exclusively on serving the intellectual and developmental disability and behavioral health communities. Beginning with services in 2007 to 150 individuals in the Tarrytown section of Austin, Texas, the company has grown to provide services in 36 states from 12 regional pharmacies.
The Carlyle Group is one of the world’s largest private equity firms. It manages more than $465 billion of assets under management, as of June 30, 2025. Carlyle employs more than 2,200 people in 29 offices across four continents.
McDermott Will & Schulte and Goodwin Procter served as legal counsel and Houlihan Lokey served as financial advisor to Tarrytown and Sheridan. Debevoise & Plimpton and Bass, Berry & Sims served as legal counsel and Wells Fargo served as financial advisor to Carlyle.
According to data captured in the LevinPro HC database, this transaction represents the 21st Specialty Pharmacy acquisition of 2025. There were 28 Specialty Pharmacy transactions announced in 2024, and 15 in 2023.
